Analysts Offer Mixed Opinions on Healthcare Stocks Ibio, MaxCyte, and Atea Pharmaceuticals

Analysts have presented mixed opinions regarding the performance and outlook of several healthcare stocks, specifically Ibio (IBIO), MaxCyte (MXCT), and Atea Pharmaceuticals (AVIR).

14 May, 14:03 — 14 May, 14:03

Post Share

Sources

Showing 1 of 1 sources

globe-and-mailHigh111d ago

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ibio (IBIO), MaxCyte (MXCT) and Atea Pharmaceuticals (AVIR) - The Globe and Mail

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ibio (IBIO), MaxCyte (MXCT) and Atea Pharmaceuticals (AVIR) The Globe and Mail

Read full article →

Analysts Offer Mixed Opinions on Healthcare Stocks Ibio, MaxCyte, and Atea Pharmaceuticals

Sources

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ibio (IBIO), MaxCyte (MXCT) and Atea Pharmaceuticals (AVIR) - The Globe and Mail

Related Stories

Pentagon Mandates Immediate Testosterone Screening for Male Troops Over 30

Singer Lionel Richie Discharged After Cardiac Evaluation

Study suggests widely used sweetener may have serious health risks

Ebola Death Toll Surpasses 3,000 in Democratic Republic of Congo